Zynerba Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
ZYNE Zynerba Pharmaceuticals Inc
XPEV Xpeng Inc
PTON Peloton Interactive Inc
PEB Pebblebrook Hotel Trust
BWG BrandywineGLOBAL ? Global Income Opportunities Fund
BPYPO Brookfield Property Partners LP
HLAHU Hamilton Lane Alliance Holdings I Inc
GUERF Guerbet SA
BTCM BIT Mining Ltd

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Health Care : Pharmaceuticals | Small Cap Value
Company profile

Zynerba Pharmaceuticals, Inc. is primarily engaged in the pharmaceutically produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, including Fragile X syndrome (FXS), autism spectrum disorder (ASD), and 22q11.2 deletion syndrome (22q). Cannabinoids are a class of compounds derived from Cannabis plants. Its two primary cannabinoids contained in cannabis are cannabidiol and tetrahydrocannabinol (THC). The Company is developing Zygel, the pharmaceutically produced cannabidiol formulated as a permeation-enhanced gel for transdermal delivery and manufactured without the presence of THC. Zygel is being developed as a clear gel with once- or twice-daily dosing and is targeting the treatment of behavioral symptoms of FXS, ASD and 22q. It has evaluated Zygel targeting the reduction of seizures in patients with a heterogeneous group of rare and ultra-rare epilepsies known as developmental and epileptic encephalopathies (DEE).


Last Trade
-0.0096 (-1.71%)
B/A Size

Market Hours

Closing Price
Day's Change
0.0227 (4.22%)
Bid close
Ask close
B/A Size
Day's High
Day's Low

10-day average volume:
  • Prev Close
  • Today's Open
  • Day's Range
  • Avg Vol (10-day)
  • Last (time)
    4:00p ET 12/01/22
  • Last (size)
  • 52-Wk Range
    0.5001 - 3.61
  • (12/09/21 - 11/22/22)
  • 76.2%
  • Market Cap
  • Shares Outstanding
  • -0.87
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 1.7
  • 23.30
  • (% of float 11/15/22)

Latest News

November 29, 2022
7:00 am ET
Globe Newswire
November 28, 2022
7:30 am ET
Globe Newswire
November 15, 2022
7:30 am ET
Globe Newswire
November 14, 2022
7:30 am ET
Globe Newswire
November 02, 2022
9:00 am ET
Globe Newswire
October 17, 2022
7:00 am ET
Globe Newswire
October 10, 2022
7:00 am ET
Globe Newswire
October 06, 2022
7:00 am ET
Globe Newswire
September 29, 2022
7:00 am ET
Globe Newswire
September 22, 2022
7:00 am ET
Globe Newswire
September 08, 2022
9:15 am ET
Globe Newswire
September 06, 2022
7:00 am ET
Globe Newswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.